Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.61 |
| ▸ | NLN | Q9BYT8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13061496 | 1.00 | LTA4H (0.62) | LTA4HCYP3A4SLC7A5NLN | |
| Hydrochloric Acid SCHEMBL27320108 | 0.99 | LTA4H (0.61) | LTA4HCYP3A4SLC7A5 | |
| SCHEMBL6816189 | 0.90 | LTA4H (0.58) | LTA4HCYP3A4SLC7A5NLN | |
| SCHEMBL3626018 | 0.87 | CYP3A4 (0.58) | LTA4HCYP3A4SLC7A5NLN | |
| SCHEMBL1007042 | 0.87 | CYP3A4 (0.61) | LTA4HCYP3A4SLC7A5NLN | |
| SCHEMBL21001107 | 0.84 | CYP3A4 (0.51) | LTA4HCYP3A4SLC7A5NLN | |
| SCHEMBL28231837 | 0.84 | CYP3A4 (0.57) | LTA4HCYP3A4SLC7A5NLN | |
| SCHEMBL11416854 | 0.83 | CYP3A4 (0.50) | LTA4HCYP3A4SLC7A5NLN | |
| SCHEMBL6114085 | 0.83 | CYP3A4 (0.62) | LTA4HCYP3A4SLC7A5NLN | |
| Phenylalanine SCHEMBL28074950 | 0.82 | SLC7A5 (0.80) | LTA4HCYP3A4SLC7A5NLN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115209912-A | Peptide compositions and methods of use thereof | 杜兰教育基金管理者 | 2022-10-18 | — | — | CN | claimed |
| CN-107556438-B | Multi-responsive cross-linked polymer, drug-loaded nano micelle and preparation method thereof | 西南民族大学 | 2020-05-12 | — | — | CN | claimed |
| US-9598288-B2 | Method for preparing zinc-histidine self-assembly biomimetric complex, zinc-histidine self-assembly complex prepared by said method, and method for reducing carbon dioxide using said zinc-histidine self-assembly complex | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2017-03-21 | — | — | US | claimed |
| US-20150151974-A1 | METHOD FOR PREPARING ZINC-HISTIDINE SELF-ASSEMBLY BIOMIMETRIC COMPLEX, ZINC-HISTIDINE SELF-ASSEMBLY COMPLEX PREPARED BY SAID METHOD, AND METHOD FOR REDUCING CARBON DIOXIDE USING SAID ZINC-HISTIDINE SELF-ASSEMBLY COMPLEX | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2015-06-04 | — | — | US | claimed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | claimed |
| CN-101906102-B | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-08-29 | — | — | CN | claimed |
| US-8124128-B2 | Amphiphilic block copolymers and nano particles comprising the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-02-28 | — | — | US | claimed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | claimed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | claimed |
| CN-101597288-B | 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof | UNIV BEIJING | 2011-08-17 | — | — | CN | claimed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | claimed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | claimed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101597288-A | 2-aminoacyl-β-Ka Lin-3-formyl tryptophan benzyl ester and its production and application | UNIV BEIJING (CN) | 2009-12-09 | — | — | CN | claimed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | claimed |
| EP-0565646-A4 | — | — | 1994-08-03 | — | — | EP | claimed |
| EP-0565646-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1993-10-20 | — | — | EP | claimed |
| WO-1992018518-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1992-10-29 | — | — | WO | claimed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | claimed |
| JP-1026596-A | — | — | None | — | — | JP | disclosed |
| WO-2023230236-A1 | PROCESS FOR PREPARING JAK INHIBITORS AND INTERMEDIATES THEREOF | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2023-11-30 | — | — | WO | disclosed |
| CN-115209912-A | Peptide compositions and methods of use thereof | 杜兰教育基金管理者 | 2022-10-18 | — | — | CN | disclosed |
| CN-114786709-A | IL-2 chimeric proteins for immunosuppression | 国家生物技术研究所公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-107556438-B | Multi-responsive cross-linked polymer, drug-loaded nano micelle and preparation method thereof | 西南民族大学 | 2020-05-12 | — | — | CN | disclosed |
| EP-3387012-A1 | VARIANTS OF AMYLOID BETA-PROTEIN PRECURSOR INHIBITOR DOMAIN | The National Institute for Biotechnology in the Negev Ltd. (IL) | 2018-10-17 | — | — | EP | disclosed |
| CN-107556438-A | Multiple response sexual intercourse linked polymer and medicament-carried nano micelle and their preparation method | 西南民族大学 | 2018-01-09 | — | — | CN | disclosed |
| WO-2017098516-A1 | VARIANTS OF AMYLOID beta-PROTEIN PRECURSOR INHIBITOR DOMAIN | The National Institute for Biotechnology in the Negev Ltd. (IL) | 2017-06-15 | — | — | WO | disclosed |
| US-9598288-B2 | Method for preparing zinc-histidine self-assembly biomimetric complex, zinc-histidine self-assembly complex prepared by said method, and method for reducing carbon dioxide using said zinc-histidine self-assembly complex | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2017-03-21 | — | — | US | disclosed |
| US-20150151974-A1 | METHOD FOR PREPARING ZINC-HISTIDINE SELF-ASSEMBLY BIOMIMETRIC COMPLEX, ZINC-HISTIDINE SELF-ASSEMBLY COMPLEX PREPARED BY SAID METHOD, AND METHOD FOR REDUCING CARBON DIOXIDE USING SAID ZINC-HISTIDINE SELF-ASSEMBLY COMPLEX | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2015-06-04 | — | — | US | disclosed |
| US-8940333-B2 | Amphiphilic block copolymers and nanoparticles comprising the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-01-27 | — | — | US | disclosed |
| CN-102250202-B | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL SCIENCES | 2013-08-28 | — | — | CN | disclosed |
| CN-102241674-B | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2012-09-12 | — | — | CN | disclosed |
| CN-101906102-B | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2012-08-29 | — | — | CN | disclosed |
| US-8138370-B2 | Method of producing optically active α-amino acid benzyl esters | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-20 | — | — | US | disclosed |
| US-8124128-B2 | Amphiphilic block copolymers and nano particles comprising the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-02-28 | — | — | US | disclosed |
| WO-2011153588-A1 | VIRAL POLYMERASE INHIBITORS | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2011-12-15 | — | — | WO | disclosed |
| CN-102250202-A | 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof | UNIV CAPITAL MEDICAL | 2011-11-23 | — | — | CN | disclosed |
| CN-102241674-A | Synthesis method and antitumor activity evaluation of 1,1-dimethyl-beta-carboline-3-formacyl amino acid benzyl ester | UNIV CAPITAL MEDICAL | 2011-11-16 | — | — | CN | disclosed |
| CN-101597290-B | Beta-carboline-3-formyl tryptophyl amine acid carbamate as well as preparation method and application thereof | UNIV CAPITAL MEDICAL | 2011-11-09 | — | — | CN | disclosed |
| CN-102164953-A | Nitrogen responsive early nodulin gene | UNIV GUELPH | 2011-08-24 | — | — | CN | disclosed |
| CN-101597288-B | 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof | UNIV BEIJING | 2011-08-17 | — | — | CN | disclosed |
| US-20100324131-A1 | Salvinorin Derivatives and Uses Thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2010-12-23 | — | — | US | disclosed |
| CN-101497615-B | Substituted purine, preparation and use in medicine | ZHEJIANG MED XINCHANG PHARM | 2010-12-15 | — | — | CN | disclosed |
| CN-101906102-A | Beta-carboline alkaloid derivative, preparation method and application thereof | UNIV CAPITAL MEDICAL | 2010-12-08 | — | — | CN | disclosed |
| US-20100203150-A1 | Novel amphiphilic copolymers and fabrication method thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2010-08-12 | — | — | US | disclosed |
| CN-1922324-B | Bacterial virulence factors and uses thereof | UNIV BRITISH COLUMBIA | 2010-06-09 | — | — | CN | disclosed |
| CN-101711861-A | bacterial virulence factors and uses thereof | UNIV BRITISH COLUMBIA | 2010-05-26 | — | — | CN | disclosed |
| US-20100010254-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACID BENZYL ESTERS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-14 | — | — | US | disclosed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | disclosed |
| CN-101597290-A | β-Ka Lin-3-formyl tryptophyl amino-acid benzyl ester and its production and application | UNIV CAPITAL MEDICAL (CN) | 2009-12-09 | — | — | CN | disclosed |
| CN-101597288-A | 2-aminoacyl-β-Ka Lin-3-formyl tryptophan benzyl ester and its production and application | UNIV BEIJING (CN) | 2009-12-09 | — | — | CN | disclosed |
| CN-101511776-A | Process for production of optically active alpha-amino acid benzyl ester | SUMITOMO CHEMICAL CO (JP) | 2009-08-19 | — | — | CN | disclosed |
| CN-101497615-A | Substituted purine, preparation and use in medicine | XINCHANG PHARMACEUTICAL FACTORY ZHEJIANG MEDICINE CO LTD (CN) | 2009-08-05 | — | — | CN | disclosed |
| EP-2062873-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ALPHA-AMINO ACID BENZYL ESTER | Sumitomo Chemical Company, Limited (JP) | 2009-05-27 | — | — | EP | disclosed |
| US-20080166382-A1 | AMPHIPHILIC BLOCK COPOLYMERS AND NANOPARTICLES COMPRISING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2008-07-10 | — | — | US | disclosed |
| US-20070104654-A1 | Amphiphilic block copolymers and nano particles comprising the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2007-05-10 | — | — | US | disclosed |
| CN-1922324-A | Bacterial virulence factors and uses thereof | UNIV BRITISH COLUMBIA (CA) | 2007-02-28 | — | — | CN | disclosed |
| US-7045532-B2 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2006-05-16 | — | — | US | disclosed |
| US-20050176017-A1 | Immobilized nucleic acid enzymes for use in medical and environmental diagnostics | YALE UNIVERSITY (US) | 2005-08-11 | — | — | US | disclosed |
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2004-04-29 | — | — | US | disclosed |
| EP-0958303-A4 | BIOREACTIVE ALLOSTERIC POLYNUCLEOTIDES | UNIV YALE (US) | 2004-03-31 | — | — | EP | disclosed |
| CN-1455680-A | MUCl extracellular domain and cancer treatment compositions and methods derived therefrom | DANA PHARBO CANCER ASS LTD (US) | 2003-11-12 | — | — | CN | disclosed |
| US-6632830-B1 | Blood pressure related disease or disorder, cell proliferation disorder, kidney disorder, kinetensin associated disorder, inflammation associated disorder, or an allergic disorder | MILLENNIUM PHARMACEUTICALS, INC. | 2003-10-14 | — | — | US | disclosed |
| US-6630306-B1 | DNA comprising a enzyme domain; interaction of a chemical effector (metal ion or small molecule) with DNA alters its cleavage function or configuration; use as biosensors | YALE UNIVERSITY | 2003-10-07 | — | — | US | disclosed |
| CN-1420926-A | Anti-angiogenic proteins and fragments and methods of use thereof | BETH ISRAEL HOSPITAL (US) | 2003-05-28 | — | — | CN | disclosed |
| CN-1377259-A | ACE-2 inhibiting compounds and methods of use thereof | MILLENNIUM PHARM INC (US) | 2002-10-30 | — | — | CN | disclosed |
| WO-2000066104-A9 | ACE-2 INHIBITING COMPOUNDS AND METHODS OF USE THEREOF | MILLENNIUM PHARM INC (US) | 2002-08-29 | — | — | WO | disclosed |
| WO-2002039997-A2 | ACE-2 MODULATING COMPOUNDS AND USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2002-05-23 | — | — | WO | disclosed |
| EP-1183019-A2 | ACE-2 INHIBITING COMPOUNDS AND METHODS OF USE THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2002-03-06 | — | — | EP | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000066104-A2 | ACE-2 INHIBITING COMPOUNDS AND METHODS OF USE THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
| EP-0958303-A1 | BIOREACTIVE ALLOSTERIC POLYNUCLEOTIDES | Yale University (US) | 1999-11-24 | — | — | EP | disclosed |
| EP-0948502-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| EP-0948506-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1999-10-13 | — | — | EP | disclosed |
| US-5945082-A | HERBICIDES, INSECTICIDES, FLAME RETARDANTS, PLASTICIZERS; CYANATION, SALT FORMATION, PHOSPHONATION, PHOSPHATING | MONSANTO COMPANY (US) | 1999-08-31 | — | — | US | disclosed |
| US-5935542-A | Cyanphosphonate derivatives and method for their preparation | MONSANTO COMPANY (US) | 1999-08-10 | — | — | US | disclosed |
| WO-1998029419-A1 | CYANOPHOSPHORUS COMPOUNDS AND THEIR PREPARATION | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998029422-A1 | CYANOPHOSPHONATE DERIVATIVES | MONSANTO COMPANY (US) | 1998-07-09 | — | — | WO | disclosed |
| WO-1998027104-A1 | BIOREACTIVE ALLOSTERIC POLYNUCLEOTIDES | YALE UNIVERSITY (US) | 1998-06-25 | — | — | WO | disclosed |
| WO-1996023490-A9 | FORMULATIONS AND METHODS FOR REDUCING SKIN IRRITATION | — | 1996-12-27 | — | — | WO | disclosed |
| CN-1109780-A | Sustained-release preparation of anti-endothelin substance | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1995-10-11 | — | — | CN | disclosed |
| EP-0565646-A4 | — | — | 1994-08-03 | — | — | EP | disclosed |
| EP-0297816-B1 | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents | PFIZER (US) | 1994-03-02 | — | — | EP | disclosed |
| EP-0266950-B1 | Nor-statine and nor-cyclostatine polypeptides | PFIZER (US) | 1993-12-29 | — | — | EP | disclosed |
| EP-0565646-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1993-10-20 | — | — | EP | disclosed |
| US-5175266-A | Oxidizing hydroxymethyl function of azidodeoxynucleosides to acid in presence of ruthenium tetroxide | TRIPLEX PHARMACEUTICAL CORPORATION (US) | 1992-12-29 | — | — | US | disclosed |
| WO-1992018518-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1992-10-29 | — | — | WO | disclosed |
| US-5110799-A | Inhibition of viral ribonucleotide reductase | MERCK & CO., INC. (US) | 1992-05-05 | — | — | US | disclosed |
| US-5034376-A | Nor-statine and nor-cyclostatine polypeptides | PFIZER INC. (US) | 1991-07-23 | — | — | US | disclosed |
| EP-0412595-A1 | Antiherpetic agents | MERCK & CO. INC. (US) | 1991-02-13 | — | — | EP | disclosed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | disclosed |
| US-4935405-A | Nor-statine and nor-cyclostatine polypeptides | PFIZER INC. (US) | 1990-06-19 | — | — | US | disclosed |
| WO-1989010751-A1 | FUNCTIONALIZED PEPTIDYL AMINODIOLS AND -TRIOLS | ABBOTT LABORATORIES (US) | 1989-11-16 | — | — | WO | disclosed |
| EP-0341602-A2 | Renin-inhibiting functionalized peptidyl aminodiols and - triols | ABBOTT LABORATORIES (US) | 1989-11-15 | — | — | EP | disclosed |
| US-4859654-A | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents | PFIZER INC. (US) | 1989-08-22 | — | — | US | disclosed |
| EP-0307837-A2 | Renin-inhibiting peptidyl heterocycles | ABBOTT LABORATORIES (US) | 1989-03-22 | — | — | EP | disclosed |
| US-4814342-A | Nor-statine and nor-cyclostatine polypeptides | PFIZER INC. (US) | 1989-03-21 | — | — | US | disclosed |
| EP-0297816-A2 | Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents | PFIZER INC. (US) | 1989-01-04 | — | — | EP | disclosed |
| EP-0266950-A2 | Nor-statine and nor-cyclostatine polypeptides | PFIZER INC. (US) | 1988-05-11 | — | — | EP | disclosed |
| US-4665056-A | CENTRAL NERVOUS SYSTEM DISORDERS | TANABE SEIYAKU CO., LTD. (JP) | 1987-05-12 | — | — | US | disclosed |
| EP-0168042-A2 | Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them | TANABE SEIYAKU CO., LTD. (JP) | 1986-01-15 | — | — | EP | disclosed |
| EP-0168042-A2 | Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them | TANABE SEIYAKU CO., LTD. (JP) | 1986-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324131-A1 | Salvinorin Derivatives and Uses Thereof | OPRK1, OPRD1, OPRM1 | LTA4H 3671/4885CYP3A4 1293/4885SLC7A5 1581/4885 |
| US-20080166382-A1 | AMPHIPHILIC BLOCK COPOLYMERS AND NANOPARTICLES COMPRISING THE SAME | EGFR, ABHD16A, TSG101 | LTA4H 2568/4885CYP3A4 4402/4885SLC7A5 513/4885 |
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | ACE, ACE2, AGTR2 | LTA4H 1191/4885CYP3A4 1491/4885SLC7A5 3222/4885 |
| US-20070104654-A1 | Amphiphilic block copolymers and nano particles comprising the same | MITF, EGFR, LNPEP | LTA4H 3123/4885CYP3A4 3778/4885SLC7A5 186/4885 |
| US-20050176017-A1 | Immobilized nucleic acid enzymes for use in medical and environmental diagnostics | RNGTT, ADA, DNTT | LTA4H 2225/4885CYP3A4 941/4885SLC7A5 4282/4885 |
| US-20100010254-A1 | METHOD OF PRODUCING OPTICALLY ACTIVE ALPHA-AMINO ACID BENZYL ESTERS | BCAT1, BCAT2, AADAT | LTA4H 1643/4885CYP3A4 992/4885SLC7A5 571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.